LIGAND PHARMACEUTICALS INCORPORATED
Profit History
| Period | Revenue | Operating Income | Net Income |
|---|---|---|---|
| Mar 2022 | $36.5M | $2.1M | $-15.4M |
| Jun 2022 | $50.1M | $8.7M | $-895.0K |
| Sep 2022 | $59.2M | $12.3M | $404.0K |
| Dec 2022 | $50.4M | — | $-17.5M |
| Mar 2023 | $44.0M | $14.2M | $41.9M |
| Jun 2023 | $26.4M | $-2.0M | $2.3M |
| Sep 2023 | $32.9M | $3.1M | $-10.3M |
| Mar 2024 | $31.0M | $3.0M | $86.1M |
| Jun 2024 | $41.5M | $-19.1M | $-51.9M |
| Sep 2024 | $51.8M | $3.1M | $-7.2M |
| Mar 2025 | $45.3M | $-36.2M | $-42.5M |
| Jun 2025 | $47.6M | $8.4M | $4.8M |
| Sep 2025 | $115.5M | $54.9M | $117.3M |
| Mar 2026 | $51.7M | $17.4M | $-13.3M |
| Jun 2026 | $63.7M | $8.6M | $48.5M |